Bhasker Sriramoju
Geelong, VIC 3216, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Corrigendum to "Brain targeted PLGA nanocarriers alleviating amyloid-Β expression and preserving basal survivin in degenerating mice model" [Biochim. et Biophys. Acta (BBA) - Mol. Basis Dis. 1852 (11) (November 2015) 2423-2431].
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: August 18, 2020
Corrigendum to "Brain targeted PLGA nanocarriers alleviating amyloid-Β expression and preserving basal survivin in degenerating mice model. Biochim Biophys Acta 2015, 1852(11):2423-31.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: October 28, 2017
Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn.
Journal: Frontiers in pharmacology
Published: April 28, 2016
Neurobehavioral burden of multiple sclerosis with nanotheranostics.
Journal: Neuropsychiatric disease and treatment
Published: October 29, 2015
Brain targeted PLGA nanocarriers alleviating amyloid-Β expression and preserving basal survivin in degenerating mice model.
Journal: Biochimica et biophysica acta
Published: April 15, 2015
Aptamer-targeted oligonucleotide theranostics: a smarter approach for brain delivery and the treatment of neurological diseases.
Journal: Current topics in medicinal chemistry
Published: February 23, 2015
Nanoformulated Mutant SurR9-C84A: a Possible Key for Alzheimer's and its Associated Inflammation.
Journal: Pharmaceutical research
Published: January 18, 2015
Lactoferrin induced neuronal differentiation: A boon for brain tumours.
Journal: International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
Published: November 10, 2014
Nanoformulated cell-penetrating survivin mutant and its dual actions.
Journal: International journal of nanomedicine
Published: July 22, 2014
Nanomedicine based nanoparticles for neurological disorders.
Journal: Current medicinal chemistry
Published: May 26, 2014
Neurological disorders and therapeutics targeted to surmount the blood-brain barrier.
Journal: International journal of nanomedicine
Published: August 01, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026